HIIFS
COLL icon

Harel Insurance Investments & Financial Services’s Collegium Pharmaceutical COLL Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,997
Closed -$41K – 720
2022
Q1 		$41K Sell
1,997
-164
-8% -$3.1K ﹤0.01% 539
2021
Q4 		$42K Buy
2,161
+741
+52% +$14.4K ﹤0.01% 610
2021
Q3 		$28K Buy
+1,420
New +$30.7K ﹤0.01% 586

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harel Insurance Investments & Financial Services's COLL Position: Q2 2022 in Review

Harel Insurance Investments & Financial Services sold out of Collegium Pharmaceutical (COLL) in Q2 2022, closing a stake of 1,997 shares — an estimated $41K sold.

Harel Insurance Investments & Financial Services first reported a position in COLL in Q3 2021 and held it in 3 quarters. The position peaked at $42K in Q4 2021. 157 funds tracked by Wall St. Rank hold COLL as of Q2 2022.

  • Harel Insurance Investments & Financial Services reported no remaining Collegium Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,997 Collegium Pharmaceutical shares in Q2 2022, an estimated $41K.
  • Harel Insurance Investments & Financial Services first reported a position in Collegium Pharmaceutical in Q3 2021 and held it in 3 quarters.
  • Harel Insurance Investments & Financial Services's Collegium Pharmaceutical position peaked at $42K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2022, filed 19 Jul 2022.